At Mayo Clinic
Seul Kee Byeon, Ph.D. obtained her Ph.D. degree in analytical chemistry from Yonsei University, South Korea. Her research was focused on using flow field-flow fractionation and LC-MS for analysis of lipids from various biological samples including plasma, urine, and tissues. She is currently working in the Pandey Lab as a joint postdoctoral fellow with Dr. Abhay Moghekar in the Department of Neurology for proteomic analysis of various neurological disorders and to develop and apply novel methodologies for proteome and lipidome analysis.
E-mail: byeon.seulkee AT mayo DOT edu
Dong-Gi Mun, Ph.D. obtained his Ph.D. degree in physical chemistry from the Korea University, South Korea. His current research interest is in development of novel analytical methodologies for comprehensive proteome profiling from various clinical samples including tissues and body fluids. He is also working on developing mass spectrometry-based clinical assay for prediction, diagnosis and monitoring of disease progression.
E-mail: mun.dong-gi AT mayo DOT edu
Kiran K. Mangalaparthi, Ph.D. obtained his Ph.D. degree from Institute of Bioinformatics. After obtaining his M.Sc. degree in Biotechnology from Osmania University, Hyderabad. he worked as a Junior Research Fellow at National Institute of Nutrition, Hyderabad on “Anti-Cancer activity of Cinnamon extract”. He is funded by a Junior Research Fellowship from UGC, Government of India. He is currently involved in the mass spectrometry-based metabolomic analysis of gastrointestinal cancers and pulmonary tuberculosis.
E-mail: mangalaparthi.kiran AT mayo DOT edu
Dr. Kishore Garapati obtained his MBBS degree from Armed Forces Medical College (AFMC) in Pune, India, and subsequently served in the Indian Navy as a primary care physician. After his service tenure, he enrolled in the joint IOB-MAHE Physician Scientist Training Program to pursue his passion for basic and translational research, and is exploring genomics and proteomics methods to improve diagnostic and therapeutic options in cancer and other diseases. He is pursuing his Ph.D. in characterizing rare diseases like congenital disorders of glycosylation at the molecular level.
E-mail: garapati.sriramkishore AT mayo DOT edu
Roman Ženka obtained his M.Sc. degree in Computer Science from Charles University, Prague. After pursuing PhD in non-photorealistic rendering he joined Mayo Clinic as a programmer/analyst to support proteomics and genomics research from the IT side. He has recently started to participate in the Proteomics Core research efforts more directly, working on development of new data processing pipelines.
E-mail: zenka.roman AT mayo DOT edu
Jinyong Kim, Ph.D. obtained his Ph.D. degree in analytical chemistry from Yonsei University, South Korea. His researches were focused on developing novel methods for advances in proteomic analysis using flow field-flow fractionation and LC-MS. His current research interest is to develop clinical assay for diagnosis of diseases by applying the cutting-edge proteomic and metabolomic methods to various biological samples.
E-mail: kim.jinyong AT mayo DOT edu
Husheng Ding, Ph.D. is an Assistant Professor of Pharmacology. He obtained his Ph.D. in structural biology from University of Science and Technology of China (USTC) and completed his postdoctoral training in the Division of Oncology Research at Mayo Clinic. His current research interest is using proteomics, bioinformatics and cellular biology approaches to study post-translational modification, protein-protein interaction, kinase inhibitors, antibody therapeutics, signal transduction and biomarker. assays.
E-mail: ding.husheng AT mayo DOT edu
Rohit Budhraja, Ph.D. obtained his Ph.D. degree in biochemistry from Technical University of Berlin, Germany for the work that he carried out at Helmholtz Centre for Environmental Research, Leipzig, Germany. His research was focused on using inductively coupled plasma mass spectrometry (ICP-MS) and LC-MS for characterization of membrane-associated metalloproteins in different anaerobically respiring microorganisms. Prior to starting his Ph.D., he worked at Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India as a Junior Research Fellow and at Lambda Therapeutic Research Ltd., Ahmedabad, India as a Research Associate. He is currently exploring mass spectrometry-based glycomics, glycoproteomics and proteomics methods to study cancer and various other diseases
E-mail: budhraja.rohit AT mayo DOT edu
Dr. Ganesh Pujari, M.D. obtained his M.D. (Pathology) degree from Maharashtra Institute of Medical Sciences and Research (MIMSR) Medical College, Latur. After completing Senior Residency from the Institute of Hematology and Transfusion Medicine (IHTM), Kolkata, he completed post-doctoral fellowship in Cytogenetics from CMC, Vellore. His current interest is translational research integrating single-cell proteomics and genomics with clinico-pathologic correlation in the diagnosis, treatment and monitoring of cancer and other rare diseases.
E-mail: pandurang.pujari AT mayo DOT edu
Richard Kandasamy, Ph.D. obtained his Ph.D. in Bioinformatics and Biotechnology from the Institute of Bioinformatics, Bangalore, India. He was a EMBO – Marie Curie postdoctoral fellow in the laboratory of Prof. Giulio Superti-Furga at the Center for Molecular Medicine, Vienna, Austria where he focused on the application of multiOmics technologies including transcriptomics, proteomics, phosphoproteomics and interaction networks to study innate immune signaling and host-pathogen interactions. He was an Associate Professor and Group Leader at the Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway for 7 years leading an interdisciplinary research group on deciphering the molecular mechanisms underlying the activation and regulation of innate immunity, inflammation, and host response to viral infections through state-of-the-art multiOmics approaches including genome-editing technologies such as CRISPR/Cas9. Dr. Kandasamy is currently an Associate Consultant II in the Department of Laboratory Medicine and Pathology, Center for Individualized Medicine at Mayo Clinic in Rochester, Minnesota, USA where he focusses on application of machine-learning and multiOmics technologies including genome-editing, network analysis, and single-cell proteomics to understand the molecular basis of various diseases including multiple myeloma for development of novel diagnostic biomarkers and potential new therapeutics.
E-mail: kandasamy.richard AT mayo DOT edu
Jun Zhong, Ph.D. is an Associate Consultant in Department of Laboratory Medicine and Pathology at Mayo Clinic. He obtained his Ph.D. in biological chemistry with Dr. Pandey as his advisor at Johns Hopkins University School of Medicine. He continued his post-doctoral training with Dr. Pandey after the graduation. Later he worked as a Senior Scientist in Omic Biosystems, Chief Scientist at Delta Omics and Principal Scientist in AlgaBT to oversee the deployment of the proteomics technology in various biological fields. After he rejoined the Pandey group at Mayo Clinic, his research interest is developing novel proteomics techniques and applying these techniques in the field of basic biomedical research and clinical research.
E-mail: zhong.jun AT mayo DOT edu
Olajide Olaleye, Ph.D. obtained his Ph.D. in Pharmacology from the University of Chinese Academy of Sciences, Beijing, China. He was a postdoctoral fellow in the laboratory for DMPK Research of Herbal Medicines, Shanghai Institute of Materia Medica where he was involved in clinical and non-clinical ADME/Pharmacokinetic and drug interaction studies of multiple compounds present in multiherb cardiovascular medicines. He has a vast experience in isolation and mass spectrometry-based pharmacokinetic studies on small-molecule natural products from various biological samples. Currently, he is engaged in development of targeted assays for small molecules that are potential novel biomarkers in various diseases.
E-mail: olaleye.olajide AT mayo DOT edu
Sandip Chavan, Ph.D. obtained his Ph.D. degree from Institute of Bioinformatics for the work he carried on head and neck cancer proteomics. He worked as Associate Scientist at Lupin Biotech, India on mass spectrometry-based characterization of biosimilars and biologics. Currently, he is applying targeted proteomics approach for developing peptide/protein multiplexed assays for proteins involved in various bleeding disorders and other diseases.
E-mail: chavan.sandip AT mayo DOT edu
Taewook Kang, Ph.D. obtained his Ph.D. from the University of Southern Denmark in 2017 under supervision of Prof. Martin R. Larsen. From 2018, he was enrolled as a postdoctoral fellow both at the University of Southern Denmark and Danish Diabetes Academy. He has gathered experience using the most comprehensive method for assessing PTMs such as phosphorylation, glycosylation, acetylation, and reversible cysteine modifications from minute amount of sample. Currently, he is engaged in single cell proteomics and O-glycoproteomics.
E-mail: kang.taewook AT mayo DOT edu
Anu Jain, Ph.D. obtained her Ph.D. degree from Post Graduate Institute of Medical Education and Research, Chandigarh, India. Her research work was focused on identifying potential salivary biomarkers for oral cancer, where she used mass spectrometer-based proteomics methods to analyze the salivary proteome. She joined Dr. Pandey’s lab as a postdoctoral fellow. Her research interest is to use proteomics methods to understand biology of diseases, like cancer, and to use these methods to improve diagnostic and therapeutic options for these diseases. She is currently using proteomics and glycoproteomics methods to study congenital disorder of glycosylation.
E-mail: jain.anu AT mayo DOT edu
Dr. Gunveen S. Sachdeva, M.D. obtained his M.B.B.S. from Armed Forces Medical College (AFMC) in Pune, India and served as a primary care physician in the Indian Armed Forces. After obtaining his M.D. in Pathology from AFMC, he worked as a Senior Resident in the Department of Laboratory Medicine at the All-India Institute of Medical Sciences (AIIMS) in New Delhi. He is currently developing methods for MALDI-imaging for spatial pathology and laser capture microdissection of formalin fixed paraffin embedded (FFPE) tissue sections for studying a variety of disorders as well as working on applying genomic and proteomic approaches in analysis of hemoglobinopathies, mitochondrial disorders and cancer. He is also involved in investigating the glycoproteome in Congenital Disorders of Glycosylation.
E-mail: sachdeva.gunveen AT mayo DOT edu
Dr. Shilpa Venkataraman obtained her M.B.B.S. degree from Kilpauk Medical College, Chennai, India followed by M.D. in Pathology from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. Her area of interest includes studying the role of innate immunity in disease processes and has worked on identifying macrophage biomarkers and significance of alternatively-activated macrophages in active lupus nephritis. At Dr. Pandey’s laboratory, she is applying laser capture microdissection and single cell multiOmics to study cancer.
E-mail: venkataraman.shilpa AT mayo DOT edu
Ramesh Bokka, Ph.D. obtained Ph. D degree in Analytical chemistry from CSIR-Indian Institute of Chemical Technology, India. My research work focus on development of LC-MS/MS methods for various small molecules including pharmaceuticals and nutraceuticals. Before joining Dr. Pandey lab, I worked as a MSCA postdoc fellow at CNR-IBBR, Italy. My current research interest is quantification of Lipid metabolite in various biological samples including plasma/serum, urine and tissues using LC-MS/MS.
E-mail: bokka.ramesh AT mayo DOT edu
Firdous Ahmad Bhat, Ph,D. obtained his M.Sc. degree in Biotechnology from University of Kashmir, J&K, India. He worked at Institute of Bioinformatics as a Ph.D. student and was funded by UGC, Government of India to carry out his research. His Ph.D. work focused on multi-omic analysis of molecular alterations induced by tobacco usage in Oral Squamous cell carcinoma. He is currently involved in the development of methodologies for targeted proteomics and post-translational modifications in various diseases.
E-mail: bhat.firdous AT mayo DOT edu
Joel-Sean Hsu, M.S. is currently a Ph.D. student at the Mayo Clinic Graduate School of Biomedical Sciences. Before joining Mayo Clinic, he received his master’s degree in Microbiology from National Taiwan University and worked as a research assistant at the Institute of Biological Chemistry, Academia Sinica. His current projects mainly use proteomics and molecular biology approaches to study tumorigenesis and drug-resistant in multiple myeloma.
E-mail: hsu.joel AT mayo DOT edu
Neha Joshi, M.Sc. obtained her M.Sc. degree in Biotechnology from Savitribai Phule Pune University, India. Subsequently, she worked as a Research Intern at Lupin Biotech where she carried out analysis and characterization of biosimilars using HPLC and LC-MS techniques. At Institute of Bioinformatics, she was involved in mass spectrometry-based proteomics analysis for identification of biomarkers and potential therapeutic targets in various diseases. She is pursuing her Ph.D. in discovery and characterization of protein biomarkers in gastric cancer using clinical samples. Currently her work is focused on glycoproteomic analysis of various congenital disorders of glycosylation, glycomics and imaging mass spectrometry using MALDI-based platform.
E-mail: joshi.neha AT mayo DOT edu